Oral self‐management of palbociclib (Ibrance®) using mobile technology protocol
Description
Abstract
Aim
This study will test the feasibility and effectiveness of mobile technology intervention on the patients’ self‐management of oral anticancer medication. Secondary objectives include acceptability, the usefulness of text messages, and